Riley Payne
About Riley Payne
Riley Payne serves as the Director of Antibody Discovery at Integral Molecular, where he has worked since 2022. He holds a Ph.D. in Cell and Molecular Biology from the University of Pennsylvania and has extensive experience in assay development, high-throughput screening, and protein purification.
Work at Integral Molecular
Riley Payne has been serving as the Director of Antibody Discovery at Integral Molecular since 2022. In this role, he leads initiatives focused on the development of novel assays for membrane transport and cell signaling. Prior to this position, he held various roles within the company, including Senior Project Leader from 2019 to 2022 and Research Scientist and Lab Manager from 2007 to 2014. His extensive experience at Integral Molecular spans over a decade, contributing to advancements in high-throughput screening and mitochondrial physiology.
Education and Expertise
Riley Payne earned a Bachelor’s degree in Biology from the University of Rochester, where he studied from 2000 to 2004. He furthered his education at the University of Pennsylvania, obtaining a Doctor of Philosophy (Ph.D.) in Cell and Molecular Biology from 2014 to 2019. His academic background supports his expertise in developing assays and skills in protein and virus production, purification, cell culture, and biochemistry.
Background
Before joining Integral Molecular, Riley Payne worked as a Lab Technician/Coordinator at Blood Centers of the Pacific from 2005 to 2006. His career in the biotech field began with this role, which provided foundational experience in laboratory operations. Following this, he transitioned to Integral Molecular, where he developed his skills and took on increasing responsibilities over the years.
Achievements
Riley Payne has a demonstrated history of leadership in risk management and biotech/healthcare consulting. His work has contributed to significant advancements in antibody discovery and assay development. His skills in high-throughput screening and mitochondrial physiology have positioned him as a key contributor in his field, particularly during his tenure at Integral Molecular.